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Overview
Researchers have been studying DES and its health effects for many years.  However, sometimes the
data and results are difficult for non-researchers to understand.  It may also be difficult for people
to figure out how research can be applied to their own health. 
This section of CDC’s DES Update will help you understand and use research about DES and
includes the following information:
• Understanding Scientific Research – Tips for interpreting and understanding scientific
research.
• Deciding Whether a Source is Reliable – Criteria for assessing whether a source is providing
accurate and reliable information.
• Role of Laboratory Animal Studies – A basis for learning about human health risks from 
laboratory animal studies.
• Role of DES Cohort Studies – An explanation for understanding how studies of the DES
cohorts (groups of DES-exposed persons who are included in follow-up research on DES-
related health effects) fit into the DES research picture.
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Understanding Scientific Research
Several journal article citations are provided in CDC’s DES Update fact sheets.  How do I read a
citation?
Knowing how to read a citation for a journal article will help you find it either at the library or on
a Web site.  The following is an example citation for a journal article about DES:
Hatch EE, Palmer JR, Titus-Ernstoff L, Noller KL, Kaufman RH, et al.  Cancer risk in women
exposed to diethylstilbestrol in utero. JAMA 1998;280(7):630-4.
The authors who wrote the article are listed first.  If there are several authors, only the first few
authors’ names will be listed, followed by “et al.”  The complete title comes next.  The name of the
journal where the study was published follows.  Oftentimes, the name of the journal will be an
acronym.  For example, in this case, JAMA stands for Journal of the American Medical Association.
The year the study was published is next.  A new issue of this journal is printed each week, so the
citation includes the volume (280) and issue number (7).  The citation also includes the page num-
bers (630-4) of the article.
If you have difficulty reading a citation or finding an article, ask a librarian for help.
Where can I find copies of scientific journal articles?
Community libraries often have copies of well-known scientific journals.  Hospital or university
libraries may have a wider range and older issues of these journals.  Some journals also have articles
available on their Web sites.  Some Web sites offer the articles free of charge, but others may require
you to register with the site and pay a nominal fee.  You will need the citation for the article to find
it either at the library or on a Web site.  See the answer to the previous question for an example
citation.
What does it mean if an article or journal is “peer reviewed?”
Scientific journals require research articles to go through a process called “peer review.” During peer
review, scientific experts who were not connected to the study review the article and decide whether
it was done properly and whether the findings have merit.  Only studies that pass peer review get
published.  
What does it mean when researchers say that results are “statistically significant?”
Because health problems occur for a variety of reasons, including chance, researchers must deter-
mine if a health effect they are studying may have occurred in study participants as a result of
chance alone.  Specifically, “statistical significance” refers to a finding in a research study that is 
larger or smaller than would be expected by chance alone.
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Statistical significance is expressed in scientific journals by a probability value (p-value).  P-values
are calculated using a statistical formula that includes the number of people and health effects being
studied and is designed to answer the question, “Could a group of this many people, who all expe-
rienced a common exposure, have had this health problem in common by chance alone?”  A find-
ing is considered statistically significant if there is less than a 5% probability (p=.05 or less) that the
findings resulted from chance.  Conversely, if there is greater than a 5% probability (p=.06 or
greater) that a finding resulted from chance, the finding is not statistically significant.  
How do I interpret statistics in research about DES-related health risks?
Understanding research about DES-related health risks without knowing how to interpret statistics
can be difficult. The following table offers some examples of how scientific studies present risk
information.
Source of risk information in this chart: Titus-Ernstoff L, et al. Long term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer 2001;84:126-33.
* The absolute risk is a number that represents the probability that an individual with a special risk factor (such as exposure to DES)
will experience a health effect (e.g., breast cancer).
** Relative risk is the comparison of disease rates (e.g., breast cancer) between persons with higher risks and those in the general pop-
ulation (who have no special exposure).
Different Ways that Statistical Risks Presented Risks Presented Type of Risk
Studies Describe Risks Phrase as Ratios as Decimals 
or Percentages
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In the general population, a woman’s life-
time risk of developing breast cancer is
about one in eight.  That means that, over
a lifetime, in a group of eight women, one
of those women would be expected to be
diagnosed with breast cancer.
For women prescribed DES while preg-
nant, lifetime risk of developing breast
cancer is one in six.  That means that,
over a lifetime, in a group of six women
exposed to DES during pregnancy, one of
those women would be expected to be
diagnosed with breast cancer.
For women prescribed DES while pregnant,
the risk for breast cancer is approximately
30% higher than for women who were not
exposed to DES during pregnancy.
One in eight 1:8 .13 or 13% Absolute risk*
One in six 1:6 .16 or 16% Absolute risk
Approximately 30% From 1:8 to 1:6 .30 or 30% Relative risk**
What is a “cohort” study?  
A “cohort” is a group of people who share common characteristics or experiences.  By compiling
and summarizing data from a cohort, scientists can observe whether disease conditions develop at
higher rates in a cohort group than they would expect in the general population. 
In this case, a DES cohort is a group of people who were exposed to DES.  Scientists have been fol-
lowing DES cohorts for several years, to evaluate their medical conditions and disease rates.
Researchers are trying to determine whether DES-exposed women and men are at an increased risk
for certain health problems compared with the general population.  For instance, one cohort study
revealed that one in six women prescribed DES while pregnant can be expected to develop breast
cancer in her lifetime, compared with an expected rate of one in eight women in the general popu-
lation (Titus-Ernstoff, 2001).
Deciding Whether a Source is Reliable
Many sources of information about DES are available.  Knowing if the information can be trusted
can be difficult.  The following are some criteria to help you consider the reliability of a source.
Where was the research published?
Health care providers trust and use research published in credible, peer-reviewed scientific journals
because experts have reviewed studies published in these journals to make sure they are of high
quality.  Some examples of credible, peer-reviewed journals are JAMA, the Journal of the National
Cancer Institute, the New England Journal of Medicine, and Science.  If you have any questions about
whether a journal is peer-reviewed, ask a librarian or your health care provider.
How does the new information fit with what is already known?
Each research study contributes to an existing body of knowledge.  Usually, more weight can be
given to study findings that support and build on the findings of other research.  If the findings of
one study contradict the findings of previous studies, months or several years may pass before more
information becomes available to support the contradictory study.  In other words, one study alone
is never enough to make a case – it simply gives direction about what new research is needed.
How does funding influence research?
Objectivity, the ability to report study results without personal bias, is an important consideration.
The source of funding for a research project may bias the reporting of results.  The funding source
is usually included in the journal article.  When reading an article from a funded research project,
you must consider whether the funders of this research had anything to gain by the results.  When
research is paid for by a source that does not have an interest in the results, funders’ expectations or
preferences were less likely to have influenced the results.
Can I trust information from television, magazines, or brochures? 
Many health reports in the media are based on articles published in peer-reviewed journals; howev-
er, some reports are not.  When you see a report on television, in a magazine, or in a brochure, you
must consider where this information came from, who provided the information, whether the
source is credible, who did the study, and whether it is consistent with other research.  If you are
unsure, ask your health care provider.
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Also remember that news stories focus on what is “new.”  So when a new study is published in a
scientific journal, reporters may highlight the results in their stories as being conclusive.  However,
a single study is never enough to make a case; new research requires other studies to support the
results before a study’s findings are considered applicable to medical practice. 
I get a lot of my information on the Internet.  Is that okay?
More and more, health-related Web sites and newsletters are available to people with Internet
access.  Use the preceding guidelines to think about the credibility, expertise, bias, and funding of
the source of information.  The most credible Internet sites come from recognized experts, like
health agencies and reputable health and medical organizations.  If you are unsure, ask your health
care provider for credible Web sites. CDC’s DES Update has a Web site for health care providers
and the public (www.cdc.gov/DES).
For a list of credible health information sources refer to the section of CDC’s DES Update titled
ADDITIONAL DES RESOURCES: Partner and Government Organizations.
I’ve heard lots of stories about DES exposure that aren’t in the research.  Why is that?
Personal stories, sometimes called “anecdotal evidence,” refer to individual experiences.  They may
or may not be consistent with scientific research.  An important element of studying large popula-
tions (like the DES cohort studies) is that individual experience is included in the reported data.
Even though you may have heard details from persons that are not consistent with findings from
scientific research, those experiences have been averaged into the population data.  Scientific evi-
dence from large studies (like the DES cohort studies) is reliable, because the studies are rigorous
and better reflect the experiences of the population that is being studied.
Role of Laboratory Animal Studies
DES can no longer be prescribed to pregnant women, even for use in clinical studies.  To project
future health risks of DES exposure, scientists are conducting animal studies with laboratory mice.
Scientists administer DES to pregnant female mice and then study the results.  Because mice age
more quickly than humans, these studies can be used to explore future health risks.  Using labora-
tory animal models allows scientists to pursue hypotheses that are not possible to research in
humans.  Results from these animal studies can also guide them on the types of diseases and health
effects to look for in humans.  Although laboratory animal studies can often predict human health
effects, because of differences between humans and mice, the results of laboratory animal studies are
not always transferable to humans.  In addition, studies of humans rely on tracking the outcomes of
DES cohorts (women and men already exposed to DES). 
Role of DES Cohort Studies
The National Cancer Institute’s (NCI) DES Combined Cohort Follow-up Study was formed in
1992.  NCI researchers brought together a large group of mothers and their children who had been
exposed to DES, as well as a group of similar (in age, medical history, etc.), but unexposed persons.
NCI recruited for this study primarily from previously studied groups and their family members.
These cohort groups were followed over a long period of time.  For this reason, new people cannot
be added to the study.
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Following is a list and brief description of the DES Cohort Studies.
• Diethylstilbestrol Adenosis Project (DESAD) – The DESAD began in 1974 at Baylor
College of Medicine, Gundersen Clinic, Massachusetts General Hospital, the Mayo Clinic, and
the University of Southern California.  The DESAD, the largest DES cohort, included 4,014
DES Daughters and 1,033 unexposed women.  Exposed women had documented evidence of
DES exposure through review of prenatal records or by physician referral.  The DESAD was
assembled to conduct studies to determine if DES Daughters were at an increased risk for
health problems related associated with their exposure to DES (Labarthe, 1978).
• DES Mothers Study – The DES Mothers Study began in 1980.  The participant group
(cohort) included approximately 3,000 women exposed to DES while pregnant and 3,000
unexposed women.  These participants had delivered babies during 1940–1960 at Boston
Lying-In Hospital, the Mayo Clinic, Dartmouth Medical School, and a private practice in
Portland, Maine.  Exposure status was determined through review of medical records.  The
cohort was created to determine if women exposed to DES during pregnancy were at increased
risk for cancer (Greenberg, 1984).
• Mayo Clinic Sons Study – The Sons Study included approximately 800 men exposed to DES
before birth (in the womb) and 600 unexposed men.  This cohort was identified by review of
medical records of women who gave birth at Mayo Clinic hospitals (Leary, 1984).
• Connecticut Mothers Study – The participants included women who delivered babies during
1946–1965 at medical offices in Fairfield and New Haven Counties, Connecticut.  The 
participants included 1,706 DES-exposed mothers and 1,405 unexposed mothers.  The 
participants are now included in the DES Combined Cohort Studies (Hadjimichael, 1984).
• Dieckmann Cohort – Participants in the group, assembled in 1974 to study DES-related
health risks, included approximately 800 women exposed to DES while pregnant and 800
unexposed mothers; approximately 400 women exposed to DES before birth (in the womb)
and 400 women in a control group; and approximately 400 men exposed to DES before birth
and 400 unexposed men.  The 1974 group comprised the second Dieckmann cohort; the first
included mothers who were participants in a study at the University of Chicago in the early
1950s.  Results based on the initial study indicated that DES was not effective in preventing
miscarriages (Dieckmann, 1953).
• British Research Medical Council (BRMC) Study – Participants included pregnant diabetic
women enrolled in clinical trial and DES Daughters and DES Sons identified through follow-
up study, for a total of 151 participants (79 DES-exposed and 72 unexposed people) (Reid,
1955).
• British Randomized Trial – A group assembled to study DES-related health effects.
Participants included women exposed to DES during pregnancy and men and women exposed
before birth (in the womb).  The DES-exposed group included 379 mothers, 144 daughters,
and 177 sons.  A control group of unexposed included 371 mothers, 170 daughters, and 163
sons (Guisti, 1995).
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• Registry for Research on Hormonal Transplacental Carcinogenesis – The Registry was
established at Massachusetts General Hospital in 1971 to track the incidence of clear cell 
adenocarcinoma (CCA) of the vagina or cervix.  The registry originally numbered 21 cases;
however, by 2002, approximately 750 cases had been recorded at the registry.  Most of the
information on treatment outcome and recurrence rates of CCA has come from the study of
patients in the registry.  The registry is now located at the University of Chicago (Department
of Obstetrics and Gynecology, The University of Chicago, 5841 South Maryland Avenue, Mail
Code 2050, Chicago, IL, 60637.  Phone: 773-702-6671. Fax: 773-702-5161) (Herbst, 1972).
What kinds of research are still going on?
Researchers continue to monitor the health status of 15,000 members of the combined cohort
study.  Many of the health problems being monitored are health problems that may be influenced
by exposure to DES before birth (in the womb).  These health problems include breast cancer in
women, testicular cancer in men, and the potential interaction of hormone replacement therapy
with DES exposure.  
Researchers also are monitoring rates of health problems that appear to have no relationship to
DES exposure (such as heart disease and diabetes).  Scientists have no hypothetical or other reason
to believe there is any link between DES and these diseases.  These studies are being done to evalu-
ate the overall health of DES-exposed persons.
Why don’t we have final answers about DES health risks?
The health risks associated with DES exposure change over a person’s lifetime. Consequently,
research is ongoing to learn how health risks change as DES-exposed persons age. 
For instance, DES Daughters who are still in their 30s may not have yet faced their risk for infertil-
ity, ectopic pregnancy, or other pregnancy complications.  Older DES Daughters and their mothers
could be just reaching the stage of life where they must make an informed decision about estrogen
replacement therapy.  Age of DES-exposed persons is particularly relevant when thinking about
DES exposure and cancer risk.  Most cancer diagnoses do not begin to emerge until people are well
into their fifth decade of life.  Men and women who were exposed to DES before birth (in the
womb) are just beginning to reach that age.  Only continued research will show whether people
who were exposed to DES before birth are at an increased risk for breast cancer, prostate cancer,
and other diseases.
UNDERSTANDING DES RESEARCH
CDC’s DES Update Toll-free 1-888-232-6789 www.cdc.gov/DES 
[ 6 ]
